Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 7

Review

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma

       
Total article views   HTML views PDF downloads Totals
11,463 Dovepress* 11,463+ 1,028 12,491
Totals 11,463 1,028 12,491
*Since 19 July 2017

View citations on Google Scholar